INHIBITORS OF GLUCOSYLCERAMIDE SYNTHASE
The hemitartrate salt of a compound represented by the following structural formula:(Formula 1 Hemitartrate), which may be used in pharmaceutical applications, are disclosed. Particular single crystalline forms of the Formula (I) Hemitartrate are characterized by a variety of properties and physical...
Saved in:
Main Authors | , , , , , , , , , , , |
---|---|
Format | Patent |
Language | English |
Published |
23.12.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The hemitartrate salt of a compound represented by the following structural formula:(Formula 1 Hemitartrate), which may be used in pharmaceutical applications, are disclosed. Particular single crystalline forms of the Formula (I) Hemitartrate are characterized by a variety of properties and physical measurements. As well, methods of producing crystalline Formula (I) Hemitartrate, and using it to inhibit glucosylceramide synthase or lowering glycosphingolipid concentrations in subjects to treat a number of diseases, are also discussed. Pharmaceutical compositions are also described. |
---|---|
Bibliography: | Application Number: US202117465994 |